SAM
NKTR icon

Storebrand Asset Management’s Nektar Therapeutics NKTR Stock Holding History

Storebrand Asset Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,058
Closed -$40.1K – 852
2024
Q3 		$40.1K Hold
2,058
– – ﹤0.01% 819
2024
Q2 		$38.3K Hold
2,058
– – ﹤0.01% 818
2024
Q1 		$28.8K Hold
2,058
– – ﹤0.01% 832
2023
Q4 		$17.4K Hold
2,058
– – ﹤0.01% 840
2023
Q3 		$18.4K Hold
2,058
– – ﹤0.01% 846
2023
Q2 		$17.8K Hold
2,058
– – ﹤0.01% 845
2023
Q1 		$21.7K Hold
2,058
– – ﹤0.01% 836
2022
Q4 		$69.8K Sell
2,058
-1,826
-47% -$88.4K ﹤0.01% 805
2022
Q3 		$186K Sell
3,884
-2,941
-43% -$175K ﹤0.01% 763
2022
Q2 		$389K Hold
6,825
– – ﹤0.01% 736
2022
Q1 		$552K Sell
6,825
-810
-11% -$120K ﹤0.01% 721
2021
Q4 		$1.55M Hold
7,635
– – 0.01% 669
2021
Q3 		$2.06M Hold
7,635
– – 0.01% 647
2021
Q2 		$1.97M Hold
7,635
– – 0.01% 664
2021
Q1 		$2.29M Hold
7,635
– – 0.01% 637
2020
Q4 		$1.95M Sell
7,635
-66
-0.9% -$17.1K 0.01% 642
2020
Q3 		$1.92M Hold
7,701
– – 0.01% 611
2020
Q2 		$2.68M Sell
7,701
-24
-0.3% -$7.49K 0.02% 532
2020
Q1 		$2.07M Buy
+7,725
New +$2.39M 0.02% 522

Other funds holding NKTR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Storebrand Asset Management's NKTR Position: Q4 2024 in Review

Storebrand Asset Management sold out of Nektar Therapeutics (NKTR) in Q4 2024, closing a stake of 2,058 shares — an estimated $40.1K sold.

Storebrand Asset Management first reported a position in NKTR in Q1 2020 and held it in 19 quarters. The position peaked at $2.68M in Q2 2020. 143 funds tracked by Wall St. Rank hold NKTR as of Q4 2024.

  • Storebrand Asset Management reported no remaining Nektar Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Storebrand Asset Management sold 2,058 Nektar Therapeutics shares in Q4 2024, an estimated $40.1K.
  • Storebrand Asset Management first reported a position in Nektar Therapeutics in Q1 2020 and held it in 19 quarters.
  • Storebrand Asset Management's Nektar Therapeutics position peaked at $2.68M in Q2 2020.
  • 143 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2024.

Based on Storebrand Asset Management's 13F filing for Q4 2024, filed 17 Jun 2026.